Re:WHO asks South African startup to replicate Moderna's mRN...
by bjoernw on Wednesday October 20, 2021 @02:38PM
(#28934367)
Is it worth optimizing for future output when the life-saving metric during a global pandemic is time-to-first-dose? There are only a few factories in the world that can make something as complex as an mRNA vaccine. There is literally a shortage in glass beakers and shipping lanes are backlogged. These supply chains are very fragile and helping stabilize those would do more for vaccine supply than what's being proposed here.
Re:WHO asks South African startup to replicate Moderna's mRN...
by munk-a on Wednesday October 20, 2021 @03:11PM
(#28934821)
I would agree if I thought this would create a significant market disturbance - but I would assume the impact of a few more competing vax manufacturers will be extremely minor.
We might see a short term dip but I don't think that additional inefficient factories would lead to less overall production unless there was something weird going on like government mandates to supply inefficient manufacturers.